Mitochondrial caseinolytic protease P activator / Anticancer agent Novel anti-cancer compound that activates early-stage integrated stress response, causing selective cancer cell death. Potently activates mitochondrial caseinolytic protease P (ClpP), resulting in eIF2α-independent induction of...
Know who made it. See the evidence. Buy through one marketplace.
Mitochondrial caseinolytic protease P activator / Anticancer agent
Novel anti-cancer compound that activates early-stage integrated stress response, causing selective cancer cell death. Potently activates mitochondrial caseinolytic protease P (ClpP), resulting in eIF2α-independent induction of ATF4 and Akt/ERK/Foxo3a/DR5/TRAIL-dependent apoptosis. Currently in clinical trials
This product is manufactured by TriBio Science and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
